Identification and Preclinical Characterization of CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase, in Lymphoma and Non-Small Cell Lung Cancer Models
CANCER RESEARCH（2011）
Key words
Cancer Cell Metabolism,Tumor Markers,Neuroblastoma,ALK
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined